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Elite young athletes with clinically silent cardiovascular disorders are at risk of sudden cardiac 
death (SCD) in competitive sports activity. SCD is caused by a variety of conditions; in middle-
aged/senior athletes, atherosclerotic coronary artery disease accounts for the vast majority of 
cases. In younger athletes, the spectrum of SCD causes is broader and includes inherited 
(cardiomyopathies) and congenital structural heart disease. Inherited ion channelopathies have 
been implicated also, with an apparently normal heart morphology identified at autopsy. SCD 
screening allows identification of athletes affected by occult conditions at a pre-symptomatic 
stage, and may lead to reduction of risk of SCD during sporting competition or training. The 
use of modern criteria for interpretation of the electrocardiogram (ECG) offers the potential to 
improve screening accuracy by reducing the number of false positives. Exercise testing in 
middle aged/senior athletes engaged in leisure sports activity is likely to be effective in 
screening significant coronary risk factors, while it is less effective in lower risk groups. 
Besides screening, the availability of automated external defibrillators at sporting environments 
is a preventative strategy to help intervene during unexpected cardiac arrest. 
 























The occurrence of a young, apparently healthy athlete dying of sudden cardiac death (SCD) during 
a competitive sporting activity is a shocking and deeply emotive  occurrence [1–4]. The leading 
cause of death in this population is an underlying structural cardiac disease [5], triggering SCD 
during physical exertion [6]. Less prevalent non-cardiac causes relate to asthma (or other 
pulmonary conditions), heat stroke, drug abuse, cerebral embolism, and ruptured cerebral artery, 
amongst other causes [7,8]. 
The athlete’s heart is defined by the physiologic adaptation in heart structure during sports 
participation over time [9–11]. These physiologic adaptations can vary between athletes due to a 
multitude of factors including genetic differences, types of training, and age and sex [12–15]. 
These adaptations can be harmful in athletes with inherited congenital heart disease, and manifest 
as pathological as opposed to physiological adaptations. The aim of the present mini-review was 
to identify the main causes of SCD in young athletes during competitive sports activities. 
 
Material & Methods  
A literature search was conducted using PubMed and ISI Web of Science databases [16]. The 
following search terms were used: ‘young athletes and cardiac’, ‘sudden death in young’, ‘cardiac 
death and sport’, ‘competitive sports and death’. Included reports and important reviews regarding 
sudden death and athletes were manually screened for additional relevant studies. Experts in the 
field, including authors from the included reports, were also requested to suggest any additional 
trials in order to ensure that the review was as comprehensive and up-to-date as possible. Only 
studies published in English were included.  
 
 
1. Exercise and SCD  
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The risk of SCD in young athletes is twice as high as in young non-athletes [17]. The most 
prevalent congenital cardiac conditions which can lead to SCD include hypertrophic 
cardiomyopathy, arrythmogenic right ventricular cardiomyopathy, congenital coronary anomalies, 
and aortic rupture [18,19]. Preventive strategies and accurate decision-making are essential for 
reducing the incidence of SCD in young athletes. Primary prevention may be feasible using pre-
competition assessments based on advanced screening methods according to international criteria 
[20,21]. These criteria are designed and developed for the evaluation of male athletes. In females, 
less developed criteria currently exist. Besides preventative strategies, availability of AED and 
trained medical staff in cardiopulmonary resuscitation during sporting events is essential for 
reducing the incidence of SCD [22,23] (Table 1). 
 
2. Mortality reduction by pre-participation screening 
Both the American Heart Association and the European Society of Cardiology consensus panel 
recommendations agree that cardiovascular screening for young competitive athletes is justifiable 
and compelling based on ethical, legal, and medical grounds [24]. Screening athletes solely on 
history and physical examination has limited sensitivity to identify the higher risk cases because 
most athletes with undetected cardiovascular disease are asymptomatic [25]. The addition of 12-
lead ECG alongside history and physical examination enhances the power of screening for the 
detection of athletes with cardiomyopathies, channelopathies, and pre-excitation syndromes at rest 
or during exercise testing [26] (Table 1). 
 
3. Undetected causes of SCD 
Autopsy studies have reported that the cause of SCD in young athletes remains undetermined in 
up to 40% of cases [27]. Inherited ion-channel disease leading to ventricular fibrillation in the 
absence of structural heart abnormalities may be responsible for some of these unidentified cases. 
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Other representative examples of these ‘hidden’ causes include so-called ‘non-ischemic, isolated 
left ventricular (LV) scar’ and ‘arrhythmic mitral valve pro-lapse’. The former of these conditions 
can be associated with life-threatening arrhythmias and SCD [28,29]. A recent autopsy study 
reported a prevalence of 25% in young athletes dying from SCD during exercise [30]. The 
diagnostic power of routine pre-participation screening for non-ischemic, isolated left ventricular 
(LV) scar is limited because ECG changes and echocardiographic LV systolic dysfunction, either 
regional or global, are not clearly identifiable in affected patients [30]. The lack of accurate  pre-
participation screening makes this condition one of the most challenging and unpredictable causes 
of SCD during sporting activities, as shown by the tragic loss of a professional Italian soccer player 
in 2012 [5,6,30] (Table 1). 
 
4. SCD in older athletes 
The risk of sports-related acute cardiovascular events, including SCD, increases exponentially in 
individuals aged ≥35 years. The main reason for SCD in this population is almost exclusively 
related to the development and progression of atherosclerotic coronary artery disease [30]. 
Identification of coronary artery disease in asymptomatic middle-aged and senior athletes may be 
challenging to detect through traditional screening methods [31]. The main causes of SCD are 




Figure 1. Causes of SCD in young athletes [32] 
 
Exercise testing with ECG is perhaps the most commonly used test due to its widespread 
availability and relatively low cost  [33,34]. However, test accuracy for detection of coronary 
artery disease is challenging within the general population. The test accuracy for identifying 
coronary artery disease increases if participants have multiple other cardiovascular risk factors. 
According to current recommendations for pre-participation cardiovascular evaluation, the 
assessment of risk is based on age, sex, blood pressure, blood cholesterol, and smoking history, 
using available scoring systems such as the ESC Systematic Coronary Risk Evaluation (SCORE) 
[35]. Maximal exercise testing (and possibly further cardiologic evaluations) should be reserved 
for those individuals embarking in moderate/intense physical activity who show an increased risk 
for coronary events [27,36] (Table 1). 
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athletes with heart 
disease 




Risks associated with 
contact sports should 






Sudden cardiac death 




A review of previous 
reports and position 
statements 
Variety of factors that 
can lead to SCD 
Catto, Dessanai, 
Sommariva, Tondo, 
& Dello Russo, 2019 
S‐ICD is effective for 
reducing the risk of 
sudden cardiac death 
in young athletes with  
arrhythmogenic 
cardiomyopathy  
Two male elite 
athletes between 20-
21 years old 
Physical activity may 




Sudden cardiac death 
in athletes 
A review of previous 
reports 
The process/protocol 
for dealing with 
sudden cardiac events 
is key to positive 
outcomes 
Post et al., 2019 A comparison of 
emergency 
preparedness between 
high school coaches 
and club sport 
coaches 
A total of 769 coaches 
were included 
Further work is 
required to raise the 
awareness of risks of 
sudden cardiac death 
in high schools and 
clubs 
Vancini et al., 2019 Prevention of sudden 
death related to sport: 
The science of basic 
life support—from 
theory to practice 
A review paper 
focused on risk 
factors associated 
with SCD  
Increasing knowledge 
and education of 
coaches with regards 
basic life support may 
help reduce risks of 
SCD. 
Cater et al., 2018 Perspectives on pre-
participation 
cardiovascular 




six physicians, and 
five associated 
personnel participated 
in a survey 
Pre participation 
cardiovascular 
screening is key to 
reducing risks 
associated with SCD. 





screening for athletes 
An opinion paper with 
key recommendations 
Screening should be 
undertaken for all 
groups to reduce risks 
of SCD 
Van Brabandt, 
Desomer, Gerkens, & 
Neyt, 2016 
Potential risks and 
benefits of screening 
young people to 
prevent SCD 




professional athletes  
Do risks/costs 





Corrado & Zorzi, 
2017 
An overview of 
sudden cardiac death 
in athletes 
Short communication 




history could be 
useful to determine 
the potential risks of 
SCD. 
Corrado & Zorzi, 
2018 
Sudden death in 
athletes 
A short report based 
on previous research 
Understanding 
individual cardiac 
history could be 
useful to determine 
the potential risks of 
SCD. 





exercise testing in 








is essential for all 
athletes 
Morrison et al., 2016 Cardiovascular pre-
participation 
screening and risk 












screening is accepted 
by Canada and is key 
to reducing the risk of 
sudden cardiac events  






report based on 
experts opinion  
Abnormal ECGs 













Table 2: Main reasons of sudden cardiac death in young athletes 
Young competitive athlete  
•Hypertrophic 
cardiomyopathy  
• Arrhythmogenic right 
ventricular cardiomyopathy  
• Idiopathic dilated 
cardiomyopathy 
 • Myocarditis  
• Coronary artery anomalies  
• Aortic dissection 
• Commotio cordis  
• Arrhythmic heart disease 
(including Wolff-
ParkinsonWhite syndrome, 






Masters athlete  
• Coronary artery disease  
• Dilated cardiomyopathy  




Effective pre-participation screening strategies are essential for reducing the risk of SCD in young 
athletes. A combination of ECG, physical examination, and assessment of family history can help 
identify individuals who may be at greater risk of SCD. However, some cardiac conditions may 
be difficult to identify through traditional screening methodologies. Within a sporting context, 
continuing education and training of coaching and medical staff remain paramount to ensure that 
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